Package 75987-150-03

Brand: uplizna

Generic: inebilizumab
NDC Package

Package Facts

Identity

Package NDC 75987-150-03
Digits Only 7598715003
Product NDC 75987-150
Product ID 75987-150_ec8e46bc-7edf-405d-8c8e-2b2f7042fcb5
Description

3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01)

Marketing

Marketing Status
Marketed Since 2020-06-11
Brand uplizna
Generic inebilizumab
Sample Package No

Linked Drug Pages (1)

UPLIZNA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "ec8e46bc-7edf-405d-8c8e-2b2f7042fcb5", "openfda": {"nui": ["N0000194013", "N0000191422"], "upc": ["0375987150032"], "unii": ["74T7185BMM"], "rxcui": ["2373955", "2373960", "2373966", "2373967"], "spl_set_id": ["834db232-afb0-4dcf-93e0-009ce8245c20"], "pharm_class_epc": ["CD19-directed Cytolytic Antibody [EPC]"], "pharm_class_moa": ["CD19-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Horizon Therapeutics USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03)  / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01)", "package_ndc": "75987-150-03", "marketing_start_date": "20200611"}], "brand_name": "UPLIZNA", "product_id": "75987-150_ec8e46bc-7edf-405d-8c8e-2b2f7042fcb5", "dosage_form": "INJECTION", "pharm_class": ["CD19-directed Antibody Interactions [MoA]", "CD19-directed Cytolytic Antibody [EPC]"], "product_ndc": "75987-150", "generic_name": "Inebilizumab", "labeler_name": "Horizon Therapeutics USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "UPLIZNA", "active_ingredients": [{"name": "INEBILIZUMAB", "strength": "10 mg/mL"}], "application_number": "BLA761142", "marketing_category": "BLA", "marketing_start_date": "20200611", "listing_expiration_date": "20261231"}